22 Paid Clinical Research Studies in Beverly Hills, California

Filtered for protocols that accept healthy volunteers or mention compensation. Always confirm stipend details and screening with the study coordinator.

Phase2

Trial of De-Intensified Post-operative Chemoradiation Following Robotic Surgery for HPV-positive Oropharyngeal Cancer

This study will enroll patients with HPV-associated oropharyngeal cancer, undergoing resection of all gross visible disease at the primary site and in the lymph nodes. A total of 4

๐Ÿ“ Tower Hematology-Oncology โ€” Beverly Hills, California

๐Ÿ’ต All eligible patients will receive de-intensified cisplatin-based chemoradiation, with high-risk patients receiving a hi

View Study & Checklist โž”
Phase1

Study to Evaluate Safety of RTx-015 Injection in Retinitis Pigmentosa or Choroideremia Patients (ENVISION)

A Phase 1, open-label, non-randomized, dose-escalation study, where approximately 18 eligible patients with retinitis pigmentosa or choroideremia will be enrolled sequentially in u

๐Ÿ“ Retina Vitreous Associates Medical Group โ€” Beverly Hills, California

๐Ÿ’ต Enrolled patients will receive a single, unilateral intravitreal injection of RTx-015 in the study eye at Visit 3 (Day 0

View Study & Checklist โž”
Phase2

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema

The goal of the LEOPARD clinical trial is to investigate a new kind of steroid eye drops, OCS-01. Macular edema is a condition in which there is collection of fluid (edema) in the

๐Ÿ“ Retina Vitreous Associates Medical Group โ€” Beverly Hills, California

๐Ÿ’ต Subjects will receive their assigned treatments until week 04, get randomized into groups and continue their assigned tr

View Study & Checklist โž”
Observational / Diagnostic

INTIBIA Pivotal Study

Prospective, randomized, double-blind, multicenter study to evaluate the safety and efficacy of an implantable tibial nerve stimulator in subjects with urgency urinary incontinence

๐Ÿ“ Cedars-Sinai Medical Group โ€” Beverly Hills, California

๐Ÿ’ต Subjects will be randomized to either INTIBIA therapeutic or INTIBIA non-therapeutic in a 2:1 ratio for the first 3 mont

View Study & Checklist โž”
Observational / Diagnostic

Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITE III)

This LIGHTSITE III study is a double-masked, sham-controlled, parallel design, prospective multi-site study for the use of PBM as a treatment for visual impairment in subjects with

๐Ÿ“ Retina Vitreous Associates Medical Group โ€” Beverly Hills, California

๐Ÿ’ต Subjects will receive repeated sham or PBM treatments at several time-points throughout the 2-year study.

View Study & Checklist โž”
Phase3

Study to Evaluate the Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection

The primary objective of this study is to assess the rates of HIV-1 infection in Men (MSM) and transgender women (TGW) who have sex with men and who are administered daily emtricit

๐Ÿ“ Clinical Research Facility โ€” Beverly Hills, California

View Study & Checklist โž”
Phase2

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer

This is a single-arm and single site phase II trial combination of chemotherapy and pembrolizumab with LBP MO-03 in 50 trial participants with early triple negative breast cancer.

๐Ÿ“ Cedars-Sinai Medical Center Beverly Hills โ€” Beverly Hills, California

๐Ÿ’ต Patients will receive standard of care pembrolizumab 200 mg every 3 weeks in concurrent with a regimen of chemotherapy.

View Study & Checklist โž”
Phase3

Study of d-MAPPSโ„ข Ophthalmic Solution in Adults With Chronic Ocular Graft-Versus-Host Disease (oGVHD)

This is a Phase III, multicenter, randomized, double-masked, vehicle-controlled, parallel-group clinical trial designed to evaluate the efficacy, safety, and tolerability of d-MAPP

๐Ÿ“ Beverly Hills Institute of Ophthalmology โ€” Beverly Hills, California

๐Ÿ’ต Eligible subjects will receive masked study treatment for 90 days, with the primary efficacy assessment performed at the

View Study & Checklist โž”
Phase1

Phase 1 Study of C.001 in Retinal Degeneration

This is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal pigment epithelium.

๐Ÿ“ Retina Vision Consultants โ€” Beverly Hills, California

๐Ÿ’ต Participants will receive a single administration of C.001 delivered by subretinal injection.

View Study & Checklist โž”
Phase1

Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma

Multiple myeloma (MM) is a plasma cell disease characterized by the growth of clonal plasma cells in the bone marrow. The purpose of this study is to assess the adverse events and

๐Ÿ“ Beverly Hills Cancer Center /ID# 266921 โ€” Beverly Hills, California

๐Ÿ’ต In phase 1 participants will receive escalating intravenous (IV) etentamig in combination with oral iberdomide.

View Study & Checklist โž”
Observational / Diagnostic

Motiva Implantsยฎ Post-Approval Study

This study examines the general post-market use and safety of Motiva Implantsยฎ and gathers and assesses selected safety and effectiveness data about their post market performance a

๐Ÿ“ The Practice Healthcare โ€” Beverly Hills, California

View Study & Checklist โž”
Phase2

Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer

This is a single institution phase II study that will enroll patients with T0-3N0-2 p16-positive oropharyngeal squamous cell carcinoma (OSCC) undergoing resection of all gross visi

๐Ÿ“ Cedars-Sinai Cancer at Beverly Hills (THO) โ€” Beverly Hills, California

๐Ÿ’ต All patients will receive a dose of 40 mg/m2 IV weekly concurrently with radiation therapy.

View Study & Checklist โž”
Interventional Protocol

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symaniยฎ Surgical System and Enabling Surgeons

The objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during free tissue transfer surgery and lymphovenous anastomos

๐Ÿ“ Cedars Sinai Medical Center โ€” Beverly Hills, California

๐Ÿ’ต Participants will receive treatment as standard of care and be asked to: * Allow the researchers to access and use thei

View Study & Checklist โž”
Phase2

A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events and change in disease activity

๐Ÿ“ Beverly Hills Cancer Center /ID# 275465 โ€” Beverly Hills, California

๐Ÿ’ต This study will have 1 arm where participants will receive telisotuzumab adizutecan.

View Study & Checklist โž”